THE EFFICACY AND SAFETY OF NEW PROKINETKC AGENT BENACHIO Q SOLN.® IN PATIENTS WITH POSTPRANDIAL DISTRESS SYNDROME SUBTYPE IN FUNCTIONAL DYSPEPSIA : A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY

Conference
UEG Week 2015


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing